CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-2,326 Cr | ₹-3,691 Cr | ₹-2,988 Cr | ₹-2,389 Cr | ₹-1,872 Cr |
What is the latest Cash Flow from Investing Activities ratio of CIPLA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-2,326 Cr |
| Mar2025 | ₹-3,691 Cr |
| Mar2024 | ₹-2,988 Cr |
| Mar2023 | ₹-2,389 Cr |
| Mar2022 | ₹-1,872 Cr |
How is Cash Flow from Investing Activities of CIPLA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2,326 Cr | Negative | |
| Mar2025 | ₹-3,691 Cr | Negative | |
| Mar2024 | ₹-2,988 Cr | Negative | |
| Mar2023 | ₹-2,389 Cr | Negative | |
| Mar2022 | ₹-1,872 Cr | - | |
Compare Cash Flow from Investing Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,475.8 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,315.0 Cr | -0.3% | -2% | 2.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2.4% |
3.4% |
-12% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses